Comparison of cryotherapy to imiquimod 5% in the treatment of anogenital warts

International Journal of STD and AIDS

Volumn 19, Issue 7, 2008, Pages 441-444

  Stefanaki, Christina ^a,b   Katzouranis, Ilias ^a   Lagogianni, Eirini ^a   Hagjivassiliou, Maria ^a   Nicolaidou, Electra ^a   Panagiotopoulos, Antonios ^a   Anyfantakis, Vassilis ^a   Bethimoutis, George ^a   Eustathios, Rallis ^a   Antoniou, Christina ^a   Katsambas, Andreas ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Anogenital warts; Cryotherapy; Imiquimod; Recurrence

Indexed keywords

IMIQUIMOD;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOTHERAPY; DRUG EFFICACY; FEVER; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTERMETHOD COMPARISON; MALE; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT DURATION; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; ADULT; AMINOQUINOLINES; ANUS DISEASES; CONDYLOMATA ACUMINATA; CRYOTHERAPY; DRUG ADMINISTRATION SCHEDULE; GENITAL DISEASES, MALE; HUMANS; MALE; RECURRENCE; TREATMENT OUTCOME;

EID: 47949094643     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2007.007196     Document Type: Article

References (23)

1. Wiley DJ, Douglas J, Beutner K, et al. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis 2002;35(suppl. 2):S210-24
2. Wiley DJ, Beutner K. Genital warts. Clin Evidence 2000;3:764-74
3. Maw R. Critical appraisal of commonly used treatment for genital warts. Int J STD AIDS 2004;15:357-64
4. Lacey CJN. Therapy for genital human papillomavirus related disease. J Clin Virol 2005;32S:S82-90
5. Abdullah AN, Walzman M, Wade A. Treatment of external genital warts comparing cryotherapy and trichloroacetic acid. Sex Transm Dis 1993;20:344-5
6. Godley MJ, Bradbeer CS, Gellan M, Thin RNT. Cryotherapy compared with trichloroacetic acid in treating genital warts. Genitourin Med 1987;63:390-2
7. Stone K, Becker T, Hagdu A, Kraus S. Treatment of external genital warts: a randomized clinical trial comparing podophyllin, cryotherapy, and electrodessication. Genitourin Med 1990;66:16-9
8. Hemmi H, Kaisho T, Takekuchi O, et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002;3:196-200
9. Tyring SK, Arany I, Stanley MA, et al. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J Inf Dis 1998;78:551-5
10. Maitland JE, Maw R. An audit of patients who have received imiquimod cream 5% for the treatment of anogenital warts. Int J STD AIDS 2000;11:268-70
11. Edwards L, Ferenczy A, Eron L, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998;134:25-30
12. Beutner KR, Spruance SL, Hougham AJ, Fox TL, Owens ML, Douglas JM Jr. Treatment of genital warts with an immune response modifier (imiquimod). J Am Acad Dermatol 1998;38:230-9
13. Vexiau D, Decuypere L, Moyse D, Aractingi S. Efficacy and safety of 5% imiquimod cream in external genital warts: a 6 months follow up evaluation. Ann Dermatol Venereol 2005;132:845-51
14. Fife KH, Ferenczy A, Douglas JM, Brown DR, Smith M, Owens ML; the HPV study group. Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily and three times a day. Sex Transm Dis 2001;28:226-31
15. Maw RD, Kinhorn GR, Bowman CA, Goh BT, Nayagam AT, Natham M. Imiquimod 5% cream is an acceptable treatment option for external anogenital warts in uncircumcised males. J Eur Acad Dermatol Venereol 2002;16:58-62
16. Gollnick H, Barasso R, Jappe U, et al. Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day. Int J STD AIDS 2001;12:22-8
17. Garland SM, Sellors JW, Wilkstrom A, et al. Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts: results of an open-label, multicentre Phase IIIB trial. Int J STD AIDS 2001;12:722-9
18. Beutner KR, Wiley DJ, Douglas JM, et al. Genital warts and their treatment. Clin Infect Dis 1999;28(suppl. 1):S37-56
19. Beutner KR, Tyring SK, Troffater KF Jr, et al. Imiquimod a patient applied immune-response modifier for treatment of external genital warts. Antimicrob Agents Chemother 1998;42:789-94
20. Edwards L, Ferenczy A, Eron L, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV study group. Human papillomavirus. Arch Dermatol 1998;134:25-30
21. Kaspari M, Gutzmer R, Kaspari T, Kap A, Brodersen JP. Application of imiquimod by suppositories (anal tampons) efficiently prevents recurrences after ablation of anal canal condyloma. Br J Dermatol 2002;147:757-9
22. Buck HW, Fortier M, Knudsen J, Paavonen J. Imiquimod 5% cream in the treatment of anogenital warts in female patients. Int J Gynecol Obstet 2002;77:231-8
23. Hubbard RA. Human papillomavirus testing methods. Arch Pathol Lab Med 2003;127:940-5